TCTR20210524002已完成4 期
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •All adult ESRD, either HD or PD, and kidney transplant recipients
排除标准
- •Active infection
- •Allograft rejection
- •Previous COVID-19 infection
- •Receiving COVID-19 vaccine prior to including in the study
研究者
相似试验
已完成
4 期
SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipientsCOVID-19Humoral immunity, cell-mediated immunity, COVID-19, immunocompromisedTCTR20210523002Faculty of Medicine Ramathibodi Hospital250
已完成
Unknown
Monitoring of immune responses following COVID-19 infection or vaccination in Bobo-Dioulasso, Burkina FasoCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN41192701Institut National de Santé Publique du Burkina Faso201
尚未招募
不适用
Can vaccination produce protective antibodies in people who fail to develop protective antibodies after recovery from COVID-19 infectioCTRI/2021/04/032572Rajiv Gandhi Cancer Institute and Research Centre
进行中（未招募）
不适用
Sarscov2 immunity Evaluation post-vaccination iN patIentS On Renal replacement therapyCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN52588893Royal Liverpool University Hospital750
终止
不适用
Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin LymphomaNon-hodgkin Lymphoma,B CellVaccination FailureNCT05050461Versailles Hospital120